Bartberger, Michael D.,Croghan, Michael D.,Fotsch, Christopher H.,Norman, Mark H.,Pennington, Lewis D.,Reichelt, Andreas,St. Jean Jr., David J.,Tegley, Christopher M.
申请号：
AU2012240233
公开号：
AU2012240233A1
申请日:
2012.04.04
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention relates to compounds of formula I or II, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
